Aya Jakobovits

2 stories about Aya Jakobovits
Aya Jakobovitz

Covid-19 was one of the biomed industry’s finest hours, says Israeli Silicon Valley veteran

15.12.20|Ron Friedman
Aya Jakobovits, a trailblazer in the biomed sector who is participating in J-Ventures’ annual investor’s conference, speaks of how the coronavirus vaccines showcased the depth of new technology
מריוס נכט 2

Allogenic Immunotherapy Company Adicet Bio Raises $80 Million

02.10.19|Meir Orbach
Founded by Israeli chemist Aya Jakobovits, Adicet develops universal immune cell therapies based on gamma delta T cells to treat different forms of cancer